Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test

Eur J Surg Oncol. 2015 Oct;41(10):1324-32. doi: 10.1016/j.ejso.2015.05.021. Epub 2015 Jul 29.

Abstract

Background: Peritoneal lavage cytology cancer-positive (CY1) is a critical prognostic factor and is taken as representing stage IV in gastric cancer. There is no consensus treatment strategy for CY1-gastric cancer, and the detailed clinicopathological features remain obscure.

Patients and methods: Among 790 gastric cancer patients between 2005 and 2009, 52 cases of CY1 were identified (6.6%). A multivariate prognostic model was applied to the univariate prognostic factors to identify independent prognostic factors and factors associated with long-term survival in CY1-gastric cancer.

Results: (1) Five-year overall survival (OS) was 17.6% in CY1-gastric cancer as compared with 93.9% in CYX and 77.7% in CY0 (77.7%), where tumors with pT2 or beyond were included in 11% of CYX, 73% of CY0, and 98% of CY1 cases. (2) On univariate analysis, factors associated with a negative prognosis were the presence of peritoneal dissemination (p = 0.029) and high preoperative serum albumin (p = 0.011) in CY1-gastric cancer. The multivariate Cox proportional hazards and logistic regression model using propensity score identified preoperative albumin as a critical independent prognostic indicator. (3) Long-term survivors were identified and, were often characterized by long-term postoperative adjuvant treatment.

Conclusion: Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival in patients with advanced gastric cancer with positive cytology test. Long-term postoperative adjuvant therapy might improve survival of patients with CY1.

Keywords: Albumin; CY1; Gastric cancer; Long-term postoperative therapy; Peritoneal dissemination; Prognosis; Propensity score.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Chemotherapy, Adjuvant
  • Cisplatin / administration & dosage
  • Disease-Free Survival
  • Docetaxel
  • Drug Combinations
  • Female
  • Gastrectomy
  • Humans
  • Hypoalbuminemia / blood*
  • Logistic Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Oxonic Acid / administration & dosage
  • Peritoneal Lavage
  • Peritoneal Neoplasms / mortality
  • Peritoneal Neoplasms / secondary*
  • Preoperative Period
  • Prognosis
  • Proportional Hazards Models
  • Retrospective Studies
  • Serum Albumin / metabolism*
  • Stomach Neoplasms / blood*
  • Stomach Neoplasms / mortality*
  • Stomach Neoplasms / pathology
  • Stomach Neoplasms / therapy
  • Taxoids / administration & dosage
  • Tegafur / administration & dosage

Substances

  • Drug Combinations
  • Serum Albumin
  • Taxoids
  • S 1 (combination)
  • Tegafur
  • Docetaxel
  • Oxonic Acid
  • Cisplatin